コンテンツへ移動
Advances in biology and therapy of multiple myeloma. / Volume 2, Translational and clinical research 資料のプレビュー
閉じる資料のプレビュー
確認中…

Advances in biology and therapy of multiple myeloma. / Volume 2, Translational and clinical research

著者: Nikhil C Munshi; Kenneth C Anderson
出版: New York ; London : Springer, ©2013.
エディション/フォーマット:   電子書籍 : Document : Englishすべてのエディションとフォーマットを見る
データベース:WorldCat
概要:
Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination  続きを読む
評価:

(まだ評価がありません) 0 件のレビュー - 是非あなたから!

件名:
関連情報:

 

オンラインで入手

この資料へのリンク

オフラインで入手

&AllPage.SpinnerRetrieving; この資料の所蔵館を検索中…

詳細

ジャンル/形式: Electronic books
その他のフォーマット: Print version:
Advances in biology and therapy of multiple myeloma. Volume 2, Translational and clinical research.
New York ; London : Springer, 2012
(OCoLC)817270653
資料の種類: Document, インターネット資料
ドキュメントの種類: インターネットリソース, コンピューターファイル
すべての著者/寄与者: Nikhil C Munshi; Kenneth C Anderson
ISBN: 9781461452607 1461452600 1461452597 9781461452591
OCLC No.: 821823520
注記: Includes index.
物理形態: 1 online resource.
コンテンツ: Myeloma Immune and Antibody Targets --
T Cell Responses in Myeloma / Ross Brown, P. Joy Ho, John Gibson, Douglas Joshua --
Novel Antigenic Targets for Immunotherapy in Myeloma / Qing Yi --
Antibody-Based Therapies in Multiple Myeloma / Yu-Tzu Tai --
Defining Multiple Myeloma as a Target for DNA Vaccines / Surinder S. Sahota, Natalia Savelyeva, Debora Joseph-Pietras, Niklas Zojer --
Harnessing Allogeneic Immunity for Anti-myeloma Response / Roberto Bellucci, Edwin P. Alyea --
Dendritic Cells and Peptide-Based Vaccine In Multiple Myeloma / Jooeun Bae, R. H. Prabhala, Nikhil C. Munshi --
New Agents --
Novel Proteasome Inhibitors / Robert Z. Orlowski --
Newer IMiDs / Abhishek Singla, Shaji Kumar. --
Novel Agents in Multiple Myeloma / Anuj Mahindra, Jacob Laubach, Constantine Mitsiades, Paul Richardson --
Early Combination Studies in Multiple Myeloma / Alessandra Larocca, Antonio Palumbo --
The Effect of Novel Anti-myeloma Agents on Bone Metabolism / Evangelos Terpos. T cell responses in myeloma --
Novel antigenic targets for immunotherapy in myeloma --
Antibody-based therapies in Multiple Myeloma --
Defining multiple myeloma as a target for DNA gene fusion vaccines --
Harnessing allogeneic immunity for anti-myeloma response --
Dendritic cell and peptide-based vaccination in myeloma --
New Proteasome inhibitors --
Newer Imids --
New agents in myeloma --
Early Combination Studies in MM --
The effect of novel antimyeloma agents on bone metabolism --
Index.\
その他のタイトル: Translational and clinical research
責任者: edited by Nikhil C. Munshi, Kenneth C. Anderson.
その他の情報:

概要:

This volume focuses on the biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel  続きを読む

レビュー

ユーザーレビュー
GoodReadsのレビューを取得中…
DOGObooksのレビューを取得中…

タグ

まずはあなたから!

類似資料

リクエストの確認

あなたは既にこの資料をリクエストしている可能性があります。このリクエストを続行してよろしければ、OK を選択してください。

リンクデータ


<http://www.worldcat.org/oclc/821823520>
library:oclcnum"821823520"
library:placeOfPublication
library:placeOfPublication
library:placeOfPublication
rdf:typeschema:Book
rdf:typeschema:MediaObject
rdf:valueUnknown value: dct
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:alternateName"Translational and clinical research"
schema:bookFormatschema:EBook
schema:contributor
schema:contributor
schema:copyrightYear"2013"
schema:datePublished"2013"
schema:description"Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. This volume will focus on biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel therapies. The book will present newer developments, providing an emphasis on basic science, as well as its significant clinical impact."
schema:description"T cell responses in myeloma -- Novel antigenic targets for immunotherapy in myeloma -- Antibody-based therapies in Multiple Myeloma -- Defining multiple myeloma as a target for DNA gene fusion vaccines -- Harnessing allogeneic immunity for anti-myeloma response -- Dendritic cell and peptide-based vaccination in myeloma -- New Proteasome inhibitors -- Newer Imids -- New agents in myeloma -- Early Combination Studies in MM -- The effect of novel antimyeloma agents on bone metabolism -- Index.\"
schema:exampleOfWork<http://worldcat.org/entity/work/id/2022960558>
schema:genre"Electronic books"
schema:inLanguage"en"
schema:name"Advances in biology and therapy of multiple myeloma. Volume 2, Translational and clinical research"
schema:publication
schema:publisher
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=523058>
schema:url<http://site.ebrary.com/id/10634854>
schema:url<http://lib.myilibrary.com?id=424647>
schema:url
schema:workExample
schema:workExample
schema:workExample
wdrs:describedby

Content-negotiable representations

ウインドウを閉じる

WorldCatにログインしてください 

アカウントをお持ちではないですか?簡単に 無料アカウントを作成することができます。.